These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11029493)

  • 1. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
    Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
    Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
    de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
    J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology.
    Morris-Stiff G; Alabraba E; Tan YM; Shapey I; Bhati C; Tanniere P; Mayer D; Buckels J; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2009 Jul; 35(7):746-50. PubMed ID: 19167859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
    Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
    Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
    Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
    Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
    Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
    Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
    Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
    Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well differentiation and intact Smad4 expression are specific features of groove pancreatic ductal adenocarcinomas.
    Izumi S; Nakamura S; Mano S; Akaki S
    Pancreas; 2015 Apr; 44(3):394-400. PubMed ID: 25426619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Oncology; 1996; 53(2):104-11. PubMed ID: 8604235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection for cancers of the pancreatic head in patients aged 70 years or over.
    Richter A; Niedergethmann M; Lorenz D; Sturm JW; Trede M; Post S
    Eur J Surg; 2002; 168(6):339-44. PubMed ID: 12428871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does lymph node ratio impact survival in resected periampullary malignancies?
    Hurtuk MG; Hughes C; Shoup M; Aranha GV
    Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.